ES2188608T3 - Derivado de ester trifluorometilpirroloindol carboxilico y proceso para su produccion. - Google Patents

Derivado de ester trifluorometilpirroloindol carboxilico y proceso para su produccion.

Info

Publication number
ES2188608T3
ES2188608T3 ES94908108T ES94908108T ES2188608T3 ES 2188608 T3 ES2188608 T3 ES 2188608T3 ES 94908108 T ES94908108 T ES 94908108T ES 94908108 T ES94908108 T ES 94908108T ES 2188608 T3 ES2188608 T3 ES 2188608T3
Authority
ES
Spain
Prior art keywords
trifluorometilpirroloindol
ester
carboxilico
derived
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94908108T
Other languages
English (en)
Inventor
Shiro Terashima
Yasumichi Fukuda
Yasuo Oomori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Sagami Chemical Research Institute
Original Assignee
Kyorin Pharmaceutical Co Ltd
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd, Sagami Chemical Research Institute filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2188608T3 publication Critical patent/ES2188608T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Laminated Bodies (AREA)

Abstract

DERIVADOS DE ESTER CARBOXILICO DE TRIFLUOROMETILPIRROLOINDOL REPRESENTADO POR LA FORMULA GENERAL (1) Y (2) QUE TIENE UNA ACTIVIDAD ANTITUMORAL ISOMEROS OPTICAMENTE ACTIVOS DE ESTOS, Y SALES FARMACEUTICAMENTE ACEPTABLES DE ESTOS, DONDE R REPRESENTA ALQUILO INFERIOR; R1 REPRESENTA UN RESIDUO DE ALFAAMINOACIDO, ETC. R2 REPRESENTA HIDROGENO, UN GRUPO PROTECTOR DE HIDROXILO, ETC; E Y REPRESENTA HALOGENO, ARILSULFONILOXI, ETC.
ES94908108T 1992-08-21 1993-08-19 Derivado de ester trifluorometilpirroloindol carboxilico y proceso para su produccion. Expired - Lifetime ES2188608T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22286292 1992-08-21
JP20425593A JP3514490B2 (ja) 1992-08-21 1993-08-18 トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法

Publications (1)

Publication Number Publication Date
ES2188608T3 true ES2188608T3 (es) 2003-07-01

Family

ID=26514369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94908108T Expired - Lifetime ES2188608T3 (es) 1992-08-21 1993-08-19 Derivado de ester trifluorometilpirroloindol carboxilico y proceso para su produccion.

Country Status (13)

Country Link
US (1) US5629430A (es)
EP (1) EP0656360B1 (es)
JP (1) JP3514490B2 (es)
KR (2) KR100312444B1 (es)
AT (1) ATE228132T1 (es)
CA (1) CA2142869C (es)
DE (1) DE69332504T2 (es)
DK (1) DK0656360T3 (es)
ES (1) ES2188608T3 (es)
HU (1) HU221041B1 (es)
PT (1) PT656360E (es)
TW (1) TW394774B (es)
WO (1) WO1994004535A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2205872A1 (en) * 1994-11-29 1996-06-06 Kyorin Pharmaceutical Co., Ltd. Acrylamide derivatives and process for production thereof
WO1998003509A1 (fr) * 1996-07-23 1998-01-29 Kyowa Hakko Kogyo Co., Ltd. Derives de dc-89
EP0972775B1 (en) * 1997-01-24 2004-12-08 Kyorin Pharmaceutical Co., Ltd. Pyrroloindole derivatives and intermediates in producing the same
US6310209B1 (en) 1997-12-08 2001-10-30 The Scripps Research Institute Synthesis of CC-1065/duocarmycin analogs
MXPA03011094A (es) * 2001-05-31 2004-12-06 Medarex Inc Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びｈｃｖ阻害剤としてのその使用
GB0403038D0 (en) 2004-02-11 2004-03-17 Novartis Ag Organic compounds
AU2005244980B2 (en) * 2004-05-19 2011-09-15 E. R. Squibb & Sons, L.L.C. Chemical linkers and conjugates thereof
RU2402548C2 (ru) * 2004-05-19 2010-10-27 Медарекс, Инк. Химические линкеры и их конъюгаты
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
ES2386366T3 (es) * 2005-02-18 2012-08-17 Medarex, Inc. Anticuerpo monoclonal humano contra el antígeno de membrana específico de la próstata (PSMA)
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
JP5290756B2 (ja) * 2005-09-26 2013-09-18 メダレックス インコーポレイテッド 抗体−薬剤コンジュゲート及びその使用
US7847105B2 (en) 2005-10-26 2010-12-07 Medarex, Inc. Methods and compounds for preparing CC-1065 analogs
WO2007059404A2 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) 2006-12-28 2013-10-21 Medarex Llc 化學鏈接劑與可裂解基質以及其之綴合物
KR20090122439A (ko) 2007-02-21 2009-11-30 메다렉스, 인코포레이티드 단일 아미노산을 갖는 화학적 링커 및 이의 접합체
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
WO2009067489A1 (en) * 2007-11-20 2009-05-28 Lankenau Institute For Medical Research Disulfide chemotherapeutic agents and methods of use thereof
HUE035798T2 (en) * 2008-11-03 2018-05-28 Syntarga Bv CC-1065 analogues and conjugates
WO2010132771A1 (en) 2009-05-15 2010-11-18 Lankenau Institute For Medical Research Methods and kits for measuring toxicity and oxidative stress in live cells
HUE030846T2 (en) 2010-04-21 2017-06-28 Syntarga Bv Conjugates of CC-1065 analogues and bifunctional linkers
AU2012395148B2 (en) 2012-11-24 2016-10-27 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
CA2935433C (en) 2014-01-10 2019-04-02 Synthon Biopharmaceuticals B.V. Duocarmycin anti-her2 antibody drug conjucates with activity against her2 expressing malignancies
CA2935430C (en) 2014-01-10 2018-09-18 Synthon Biopharmaceuticals B.V. Duocarmycin adcs for use in treatment of endometrial cancer
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
US20210308277A1 (en) 2016-11-14 2021-10-07 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers
CN112724068A (zh) * 2020-12-30 2021-04-30 蔡桂坡 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978757A (en) * 1984-02-21 1990-12-18 The Upjohn Company 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds
JP2598116B2 (ja) * 1988-12-28 1997-04-09 協和醗酵工業株式会社 新規物質ｄｃ１１３
JP2510335B2 (ja) * 1989-07-03 1996-06-26 協和醗酵工業株式会社 Ｄｃ―８８ａ誘導体
JP3037965B2 (ja) * 1990-06-20 2000-05-08 財団法人相模中央化学研究所 ２―アルコキシカルボニル―２―メチル―１―オキソ―１，２，３，６，７，８―ヘキサヒドロ―ベンゾ〔１，２―ｂ；４，３―ｂ´〕ジピロール誘導体
JPH0499774A (ja) * 1990-08-14 1992-03-31 Sagami Chem Res Center ２―エピデュオカルマイシンａおよびその製造中間体

Also Published As

Publication number Publication date
JP3514490B2 (ja) 2004-03-31
DE69332504T2 (de) 2003-10-02
DK0656360T3 (da) 2003-03-17
CA2142869C (en) 2002-01-01
HU9500494D0 (en) 1995-04-28
AU4761893A (en) 1994-03-15
WO1994004535A1 (en) 1994-03-03
PT656360E (pt) 2003-02-28
EP0656360A4 (en) 1995-08-30
ATE228132T1 (de) 2002-12-15
EP0656360B1 (en) 2002-11-20
HUT71493A (en) 1995-11-28
US5629430A (en) 1997-05-13
JPH06116269A (ja) 1994-04-26
TW394774B (en) 2000-06-21
EP0656360A1 (en) 1995-06-07
CA2142869A1 (en) 1994-03-03
HU221041B1 (hu) 2002-07-29
KR100312444B1 (ko) 2002-02-28
AU689443B2 (en) 1998-04-02
KR100312445B1 (ko) 2001-11-09
DE69332504D1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
ES2188608T3 (es) Derivado de ester trifluorometilpirroloindol carboxilico y proceso para su produccion.
AR053946A2 (es) Variante de alfa-amilasa de bacillus stearothermophilus original
ES2175127T3 (es) Derivados de la quinazolina y su uso.
BG105556A (en) New esters derived from substituted phenyl-cyclohexyl compounds
SE9502168D0 (sv) Insulinanalog-kompositioner
ES2195970T3 (es) L-ribavirina y usos de la misma.
BG104780A (en) Inhibitors of phospholipase enzymes
ES2185338T3 (es) Derivados de fumagilol y procedimientos para su fabricacion.
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
UY26242A1 (es) Nueva formulacion ley 17164
ATE192649T1 (de) Stereochemische wortmanninderivate
ATE49203T1 (de) Leukotrien-antagonisten.
NO306930B1 (no) Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel
ES2040206T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
ES2071663T3 (es) Analogo de fluoxetina.
AR013462A1 (es) Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos
MX9102518A (es) Dicarbonatos y uretanos de acido 4,5,-dihidroxi y 4,5,8,-trihidroxi-9,10-dihidro-9,10-dioxi-2-1-antracencarboxilico que tiene actividad terapeutica.
IT8421921A0 (it) Procedimento per la produzione di l-amminoacidi da alfa-chetoacidi.
FI944051A (fi) Aspergillus nigerin katalaasi-R:n tuotanto
IT1285777B1 (it) Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
ES2110258T3 (es) Derivados de 1,3,5(10)-estratrieno activos por via oral.
AR027578A1 (es) Derivados de indano
IT8222059A0 (it) Procedimento catalitico per laproduzione di alcanoli da gas disintesi.
AR027327A1 (es) Procedimiento para la separacion einzimatica de racematos de derivados de aminometil-aril-ciclohezanol
ES2091285T3 (es) 2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina.